Moringa Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer - Pharmagen group · Lahore · Pakistan
Lahore-based pharmaceutical manufacturer and Pharmagen subsidiary producing branded and generic medicines from a purpose-built cGMP facility.
Moringa Pharmaceuticals products in Pakistan
Moringa Pharmaceuticals (Pvt) Ltd has 35 medicine presentations registered in Pakistan under 19 brands, covering 19 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Vitamins, minerals & nutrition. Its brands with the most registered strengths and packs are Ringacip (Ciprofloxacin), Azydec (Azithromycin), Safpep (Omeprazole enteric coated pellets, Omeprazole) and Triomor (Ceftriaxone). 35 products have an official DRAP price on MedInfoBase. See all 19 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Moringa Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer - Pharmagen group
- Address
- 35-A, Sundar Industrial Estate, Raiwind, Lahore, Punjab, Pakistan
- Website
- moringapharmaceuticals.com ↗
- Corporate source details checked
- 22 Oct 2026
- Corporate profile completeness
- 75%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Moringa Pharmaceuticals (Pvt) Ltd. is priced against the market
35 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Amphozole | Fluconazole | 150 mg | Capsule | 1's | 074459 | PKR 179.52 | PKR 179.52/capsule | 🔒 Pharma Pro |
| Arezotum | Piperacillin + tazobactam | 4 g + 0.5 g | Injection | 1's | 106883 | PKR 1,596.48 | PKR 1,596.48/vial/unit | 🔒 Pharma Pro |
| Azydec | Azithromycin | 250 mg | Capsule | 1X10's | 074458 | PKR 508.65 | PKR 50.87/capsule | 🔒 Pharma Pro |
| Azydec | Azithromycin | 200 mg/5 mL | Dry suspension | 15ml | 074468 | PKR 329.13 | PKR 21.94/mL | 🔒 Pharma Pro |
| Azydec | Azithromycin | 500 mg | Tablet | 6's | 104668 | PKR 495.67 | PKR 82.61/tablet | 🔒 Pharma Pro |
| Clarimor | Clarithromycin | 500 mg | Tablet | 10's | 074456 | PKR 887.64 | PKR 88.76/tablet | 🔒 Pharma Pro |
| Clarimor | Clarithromycin | 250 mg | Tablet | 10's | 074457 | PKR 478.73 | PKR 47.87/tablet | 🔒 Pharma Pro |
| Clarimor Dry | Clarithromycin | 125 mg/5 mL | Dry suspension | 60ml | 076958 | PKR 444.82 | PKR 7.41/mL | 🔒 Pharma Pro |
| Clarimor Dry | Clarithromycin | 125 mg/5 mL | Dry suspension | 30ml | 076958 | PKR 219.42 | PKR 7.31/mL | 🔒 Pharma Pro |
| Feromor-S | Iron protein succinylate | 800 mg/15 mL | Syrup | 120ml | 076898 | PKR 331.63 | PKR 2.76/mL | 🔒 Pharma Pro |
| Feromor-S | Iron protein succinylate | 800 mg/5 mL | Syrup | 60ml | 076898 | PKR 195.68 | PKR 3.26/mL | 🔒 Pharma Pro |
| Gem-ton 40mg IM InjectionRegistry verified | Esomeprazole as sodium | — | — | — | 106878Official source ↗ | No indexed price | — | — |
| Ibumor | Ibuprofen | 100 mg/5 mL | Suspension | 90ml | 074464 | PKR 79.13 | PKR 0.88/mL | 🔒 Pharma Pro |
| Levo-M | Levofloxacin | 250 mg | Tablet | 10's | 074450 | PKR 498.67 | PKR 49.87/tablet | 🔒 Pharma Pro |
| Levo-M | Levofloxacin | 500 mg | Tablet | 1X10's | 074451 | PKR 829.79 | PKR 82.98/tablet | 🔒 Pharma Pro |
| Moribect 1g InjectionRegistry verified | Cefoperazone as sodium, Sulbactam as Sodium | — | — | — | 106875Official source ↗ | No indexed price | — | — |
| Moribect 2g InjectionRegistry verified | Cefoperazone as sodium, Sulbactam as Sodium | — | — | — | 106876Official source ↗ | No indexed price | — | — |
| Moringa-Lact | Lactulose | 3.35 g/5 mL | Syrup | 120ml | 077043 | PKR 304.85 | PKR 2.54/mL | 🔒 Pharma Pro |
| Moripime 1g InjectionRegistry verified | Cefepime HCl with L-arginine eq. to Cefipime (anhydrous) | — | — | — | 106874Official source ↗ | No indexed price | — | — |
| Moripime 500mg InjectionRegistry verified | Cefepime | — | — | — | 106873Official source ↗ | No indexed price | — | — |
| Myriva | Moxifloxacin | 400 mg | Tablet | 5's | 074453 | PKR 947.48 | PKR 189.50/tablet | 🔒 Pharma Pro |
| Paramor | Paracetamol | 500 mg | Tablet | 200's | 123879 | PKR 589.36 | PKR 2.95/tablet | 🔒 Pharma Pro |
| Ribamor | Ribavirin | 400 mg | Capsule | 10's | 097524 | PKR 185.88 | PKR 18.59/capsule | 🔒 Pharma Pro |
| Ringacip | Ciprofloxacin | 250 mg | Tablet | 10's | 074448 | PKR 259.31 | PKR 25.93/tablet | 🔒 Pharma Pro |
| Ringacip | Ciprofloxacin | 500 mg | Tablet | 10's | 074449 | PKR 428.86 | PKR 42.89/tablet | 🔒 Pharma Pro |
| Ringacip | Ciprofloxacin | 125 mg/5 mL | Dry suspension | 60ml | 074466 | PKR 179.52 | PKR 2.99/mL | 🔒 Pharma Pro |
| Ringacip | Ciprofloxacin | 250 mg/5 mL | Dry suspension | 60ml | 074467 | PKR 319.15 | PKR 5.32/mL | 🔒 Pharma Pro |
| Ringavir | Oseltamivir | 75 mg | Capsule | 10's | 102648 | PKR 1,548.98 | PKR 154.90/capsule | 🔒 Pharma Pro |
| Safpep | Omeprazole enteric coated pellets | 20 mg | Capsule | 2X7's | 076950 | PKR 279.26 | PKR 19.95/capsule | 🔒 Pharma Pro |
| Safpep | Omeprazole enteric coated pellets | 40 mg | Capsule | 2X7's | 076951 | PKR 478.73 | PKR 34.20/capsule | 🔒 Pharma Pro |
| Safpep | Omeprazole | 40 mg | Injection | 1's | 106882 | PKR 619.59 | PKR 619.59/vial/unit | 🔒 Pharma Pro |
| Triomor | Ceftriaxone | 1 g | IV injection | 1's | 107197 | PKR 662.96 | PKR 662.96/vial/unit | 🔒 Pharma Pro |
| Triomor | Ceftriaxone | 250 mg | Injection | 1's | 107198 | PKR 208.60 | PKR 208.60/vial/unit | 🔒 Pharma Pro |
| Triomor | Ceftriaxone | 500 mg | IM injection | 1's | 107199 | PKR 351.10 | PKR 351.10/vial/unit | 🔒 Pharma Pro |
| Vidaquin | Hydroxychloroquine | 200 mg | Tablet | 50's | 102647 | PKR 929.39 | PKR 18.59/tablet | 🔒 Pharma Pro |
| Vidaquin | Hydroxychloroquine | 200 mg | Tablet | 30's | 102647 | PKR 557.63 | PKR 18.59/tablet | 🔒 Pharma Pro |
| Ximemor | Cefixime | 400 mg | Capsule | 1X5's | 107200 | PKR 592.04 | PKR 118.41/capsule | 🔒 Pharma Pro |
| Ximemor | Cefixime | 100 mg/5 mL | Dry suspension | 30ml | 107201 | PKR 330.39 | PKR 11.01/mL | 🔒 Pharma Pro |
| Ximemor | Cefixime | 200 mg/5 mL | Dry suspension | 30ml | 109609 | PKR 404.33 | PKR 13.48/mL | 🔒 Pharma Pro |
| Xorb-A | Ascorbic acid | 500 mg | Chewable tablet | 40's | 102649 | PKR 64.34 | PKR 1.61/tablet | 🔒 Pharma Pro |
All 19 Moringa Pharmaceuticals brands in Pakistan
- Amphozole Fluconazole · 150 mg capsule
- Arezotum Piperacillin + tazobactam · 4 g + 0.5 g injection
- Azydec Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
- Clarimor Clarithromycin · 250 mg tablet, 500 mg tablet
- Clarimor Dry Clarithromycin · 125 mg/5 mL suspension
- Feromor-S Iron protein succinylate · 800 mg/15 mL syrup, 800 mg/5 mL syrup
- Ibumor Ibuprofen · 100 mg/5 mL suspension
- Levo-M Levofloxacin · 250 mg tablet, 500 mg tablet
- Moringa-Lact Lactulose · 3.35 g/5 mL syrup
- Myriva Moxifloxacin · 400 mg tablet
- Paramor Paracetamol · 500 mg tablet
- Ribamor Ribavirin · 400 mg capsule
- Ringacip Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- Ringavir Oseltamivir · 75 mg capsule
- Safpep Omeprazole enteric coated pellets, Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Triomor Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Vidaquin Hydroxychloroquine · 200 mg tablet
- Ximemor Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg capsule
- Xorb-A Ascorbic acid · 500 mg tablet
Moringa Pharmaceuticals: common questions
How many products does Moringa Pharmaceuticals have in Pakistan?
Moringa Pharmaceuticals (Pvt) Ltd has 35 registered medicine presentations in Pakistan, sold under 19 brands and covering 19 generic medicines.
What are the main brands of Moringa Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Ringacip (Ciprofloxacin), Azydec (Azithromycin), Safpep (Omeprazole enteric coated pellets, Omeprazole), Triomor (Ceftriaxone) and Ximemor (Cefixime). This is not a sales ranking.
Which therapy areas does Moringa Pharmaceuticals cover?
The most products are in Anti-infectives (26), Gastrointestinal & hepatology (4), Vitamins, minerals & nutrition (3) and Pain & musculoskeletal (2).
Where can I see Moringa Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.